方法：对36例39眼因青光眼行小梁切除术后2～12wk滤过泡功能不良者进行MMC 0.1mL(0.2mg/mL)结膜下注射联合针拨治疗，平均治疗1.31±0.58次，观察眼压、滤过泡和并发症.并随访3mo。

结果：治疗后3mo时平均眼压为15.8±6.6mmHg，显著低于治疗前平均眼压27.4±5.7mmHg； 成功滤过泡32眼，成功率为82.1%。结膜下出血7眼，浅前房低眼压1眼，无伤口渗漏和脉络膜渗漏等并发症。

结论：MMC结膜下注射联合针拨治疗小梁切除术后功能不良滤过泡是安全、简单、有效的方法。

METHODS: MMC 0.1mL(0.2mg/mL)subconjuctival injection with needling revision was performed on 39 eyes of 36 patients with dysfunctional filtering blebs 2～12wk after trabeculectomy for glaucoma. An average of 1.31±0.58 times of treatment was performed. The intraocular pressure(IOP), blebs and complications were observed and follow up was conducted for 3mo.

RESULTS: Three months after treatment, the mean IOP was 15.8±6.6mmHg, significantly lower than that of before treatment(27.4±5.7mmHg). There were 32 eyes with successful filtering blebs, with the success rate of 82.1%. Subconjuctiva hemorrhage occurred in 7 eyes, shallow anterior chamber and hypotony occurred in 1 eye, No such complications as leakage of the wound and choroidal effusion were observed during the follow up.

CONCLUSION: MMC subconjuctival injection with needling revision is a safe, simple and effective method for dysfunctional filtering blebs after trabeculectomy.